Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up

Podobné jednotky

• Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
  Autor: Caorsi, R, a další
  Vydáno: (2011)
• The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
  Autor: Caorsi, Roberta, a další
  Vydáno: (2013)
• National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry
  Autor: Bibalo, C, a další
  Vydáno: (2011)
• Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
  Autor: Toker, Ori, a další
  Vydáno: (2010)
• The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience
  Autor: Svetlana Olegovna Salugina, a další
  Vydáno: (2014-12-01)